ABVC BioPharma, Inc. (ABVC) vs TherapeuticsMD, Inc. (TXMD)
A side-by-side comparison of ABVC BioPharma, Inc. and TherapeuticsMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABVC
ABVC BioPharma, Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
TXMD
TherapeuticsMD, Inc.
$2.00HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — ABVC vs TXMD
growth of $100 · dividends reinvested · last 10yABVC -99.7% (-44.6%/yr)TXMD -99.4% (-40.0%/yr)TXMD compounded faster over this window
ABVC TXMD
ABVC vs TXMD: by the numbers
- •ABVC is the larger company ($24M vs $23M market cap).
- •Both run net losses; ABVC's is the smaller (0.00% vs -6.64% net margin).
Metrics side by side
Valuation
| Metric | ABVC | TXMD |
|---|---|---|
| Forward P/E | N/A | 11.76 |
| P/S ratio | N/A | 7.08 |
| P/B ratio | 2.35 | 0.85 |
| FCF yield | N/A | 13.48% |
Profitability
| Metric | ABVC | TXMD |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -139.44% |
| Net margin | 0.00% | -6.64% |
| ROE | -76.82% | -0.80% |
| ROIC | -53.34% | -11.84% |
Growth (annualized)
| Metric | ABVC | TXMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -47.86% |
| Total return CAGR (5Y) | -46.33% | -44.16% |
Frequently asked
- How have ABVC and TXMD total returns compared?
- Over the past 10 years, ABVC delivered -44.60% and TXMD delivered -40.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ABVC BioPharma ROETherapeuticsMD ROEABVC BioPharma operating marginTherapeuticsMD operating marginABVC BioPharma revenue growthTherapeuticsMD revenue growthABVC BioPharma free cash flowTherapeuticsMD free cash flow
ABVC BioPharma & TherapeuticsMD appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.